Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neuromuscular Junction And Blockade

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

The Neuromuscular Junction

The Neuromuscular Junction

The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Modified-Release Drug Delivery Systems: Rate-Programmed I

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and efficacy of encorafenib-cetuximab combination in <i>BRAF</i> <sup><i>V600E</i></sup> -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.

ESMO real world data and digital oncology·2026

Same author

Automatic milking unit preference of Holstein, Jersey, and Holstein-Jersey crossbred cows in a batch milking system.

Journal of dairy science·2025

Same author

Scaling Law for Epithelial Tissue Rheology.

Physical review letters·2025

Same author

The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of Topography.

Tribology letters·2025

Same author

Milking behavior and performance of primiparous and multiparous Holstein, Jersey, and Holstein × Jersey crossbred cows in a batch milking system with automatic milking units.

Journal of dairy science·2025

Same author

Perivascular epithelioid cell tumors (PEComas) of gynecological tract: preoperative diagnostic imaging challenge.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023

Search research articles

Related Experiment Video

Updated: May 9, 2026

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

Flexible communication and control protocol for injectable neuromuscular interfaces.

N Rodriguez, J Weissberg, G E Loeb

IEEE Transactions on Biomedical Circuits and Systems

|July 16, 2013

Summary

This summary is machine-generated.

BION2 uses injectable neuromuscular implants with sensors to restore movement in paralyzed limbs. Its novel architecture optimizes communication for precise control and minimizes errors, enhancing functional recovery.

More Related Videos

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

Published on: January 13, 2022

Fabrication of the Composite Regenerative Peripheral Nerve Interface (C-RPNI) in the Adult Rat

Fabrication of the Composite Regenerative Peripheral Nerve Interface (C-RPNI) in the Adult Rat

Published on: February 25, 2020

Related Experiment Videos

Last Updated: May 9, 2026

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

Published on: January 13, 2022

Fabrication of the Composite Regenerative Peripheral Nerve Interface (C-RPNI) in the Adult Rat

Fabrication of the Composite Regenerative Peripheral Nerve Interface (C-RPNI) in the Adult Rat

Published on: February 25, 2020

Area of Science:

Biomedical Engineering
Neuroprosthetics
Rehabilitation Technology

Background:

Paralysis significantly impacts quality of life, necessitating advanced solutions for restoring limb function.
Existing neuroprosthetic systems face challenges in integrated sensing, precise control, and robust communication.
Injectable neuromuscular implants offer a promising approach for advanced motor function restoration.

Purpose of the Study:

To present a novel communication and control architecture for the BION2 system.
To address functional requirements including patient intention detection, muscle activation servocontrol, and posture sensing.
To overcome technical constraints such as limited telemetry capacity and power loss.

Main Methods:

Development of an integrated communication and control architecture for injectable neuromuscular implants.
Implementation of features for efficient telemetry, error mitigation, and power management.
Design for adjustable stimulation parameters to achieve fine motor control and minimize muscle fatigue.

Main Results:

The proposed architecture effectively integrates sensing and stimulation for functional movement restoration.
Efficient use of limited telemetry channels and robust handling of data errors and power interruptions were demonstrated.
The system allows for fine-tuning of stimulation to achieve precise muscle force control and reduce fatigue.

Conclusions:

The BION2 communication and control architecture provides a viable solution for restoring functional movement in paralyzed limbs.
Novel features enhance system reliability, control precision, and user experience in neuroprosthetic applications.
This work advances the field of neuroprosthetics by offering a comprehensive system for motor function restoration.